SCHEMBL5147889

SCHEMBL5147889

COc1cc(-c2ccccc2)ccc1Nc1snnc1C(N)=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ILK Q13418 3/20 0.55
KDM4E B2RXH2 1/20 0.49
APAF1 O14727 1/20 0.49
RECQL P46063 1/20 0.49
CASP6 P55212 1/20 0.49
CACNA1B Q00975 1/20 0.49
APBA1 Q02410 1/20 0.49
MCL1 Q07820 1/20 0.49
CASP8 Q14790 1/20 0.49
CAMKK2 Q96RR4 2/20 0.45
PIK3CG P48736 1/20 0.45
ABCB1 P08183 3/20 0.41
ABCC1 P33527 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
IRAK4 Q9NWZ3 1/20 0.40
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5147610 0.77 ILK (0.50) ILKMEN1KMT2APOLBHTT
SCHEMBL5147658 0.75 ILK (0.60) ILKKDM4EMEN1KMT2APOLB
SCHEMBL5147602 0.72 ILK (1.00) ILKMEN1KMT2APOLBHTT
SCHEMBL5149308 0.71 ILK (0.64) ILKMEN1KMT2APOLBHTT
SCHEMBL5147550 0.71 ILK (0.65) ILKKDM4EMEN1KMT2APDE4B
SCHEMBL5147749 0.70 ILK (0.68) ILKKDM4ERECQLMEN1KMT2A
SCHEMBL2471373 0.69 RECQL (0.44) KDM4EAPAF1RECQLCASP6CACNA1B
SCHEMBL5147719 0.69 ILK (1.00) ILKKDM4EMEN1KMT2APOLB
SCHEMBL29073121 0.68 KDM4E (0.51) KDM4EAPAF1RECQLCASP6CACNA1B
SCHEMBL1720516 0.67 KDM4E (1.00) KDM4EAPAF1RECQLCASP6CACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7288556-B2 Antiproliferative 1,2,3-thiadiazole compounds QLT INC. (CA) 2007-10-30 US disclosed
US-7022702-B2 Antiproliferative 1,2,3-thiadiazole compounds QLT INC. (CA) 2006-04-04 US disclosed
US-20060009500-A1 Antiproliferative 1,2,3-thiadiazole compounds QLT INC. (CA) 2006-01-12 US disclosed
US-20030096848-A1 Antiproliferative 1,2,3-thiadiazole compounds DERMIRA (CANADA), INC. 2003-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096848-A1 Antiproliferative 1,2,3-thiadiazole compounds CCNA1, CCND1, CCND3 ILK 1286/4885KDM4E 4288/4885APAF1 1339/4885
US-20060009500-A1 Antiproliferative 1,2,3-thiadiazole compounds CCNA1, CCND3, ACIN1 ILK 2862/4885KDM4E 4395/4885APAF1 695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.